Abridge Expands AI Documentation Capabilities with Pediatric Well Visit Template

Artificial intelligence (AI) clinical documentation startup Abridge has unveiled a new medical record template specifically designed for pediatric primary care well visits, marking a significant advancement in the company's mission to streamline healthcare documentation.

Tailored AI for Pediatric Care

Abridge's latest offering leverages ambient AI technology and a "contextual reasoning engine" to automatically detect the nature of pediatric medical visits and generate appropriate notes. The template is structured to accommodate the unique requirements of well baby and well child visits, including assessments of growth, development, diet, sleep, immunizations, and vision and hearing evaluations.

Dr. Shiv Rao, CEO and founder of Abridge, emphasized the importance of this development: "Well visit is interesting because it's a specific note type and it has specific content associated with it. We need to ensure that we can recognize, first of all, the way people say all the different terms."

The new template organizes the History of Present Illness around key subsections and lists Well Visit and Anticipatory Guidance as primary problems in the Assessment and Plan. This structure allows for seamless integration of information into existing medical record systems.

Collaborative Development and Clinical Impact

The pediatric well visit template was developed in collaboration with pediatricians from partner health systems and with input from two pediatricians on Abridge's staff. This collaborative approach has resulted in a tool that not only meets technical requirements but also addresses the practical needs of healthcare providers.

Dr. Joel Davidson, a pediatrician at Akron Children's Hospital, highlighted the personal touch that Abridge's technology brings to patient care: "The note feeling personal is one of the best parts of Abridge, and I think it's one of the most important things that's going to transform medicine. It's transformed the way that I communicate with families."

Expanding Reach and Future Developments

Abridge's technology has now been deployed in over 100 health systems, reflecting the growing demand for AI-assisted clinical documentation. The company has raised more than $460 million to date, including a recent $250 million Series D funding round that valued the company at $2.75 billion.

As the AI scribe market continues to boom, Abridge is focusing on developing specialized tools for various medical specialties and settings. Dr. Rao outlined the company's strategy: "What we're in the midst of is just going millions of miles deep on every single one of those specialties in every single one of those different settings."

With the success of its pediatric well visit template and ongoing collaborations with major healthcare institutions, Abridge is poised to further revolutionize clinical documentation across the healthcare spectrum.